Clinical trial · no report yet · Phase 2
NCT06840483
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
- NCT06840483 ↗
- Active, not recruiting
- BicycleTx Limited
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 4 |
The trial
ClinicalTrials.gov- Official title
- Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Zelenectide pevedotin (BT8009)
- Arms
- Cohort A (HR+/HER2-negative breast cancer) · Experimental
- Cohort B (TNBC) · Experimental
- Enrollment
- 66 (estimated)
- Primary outcomes
- Objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors per RECIST version 1.1 as assessed by the Investigator
- Sponsor
- BicycleTx Limited
- Start
- Mar 3, 2025
- Primary completion
- Jun 30, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06840483 · updated Apr 15, 2026